Filed with ASX · · 4 pages · English
Proteomics International Laboratories Ltd has launched a Share Purchase Plan to invite eligible shareholders to participate in raising funds. The plan aims to raise funds for commercial execution, clinical programs, and market readiness initiatives. Eligible shareholders can subscribe for new shares at a discounted price, with additional options offered as incentives. An investor webinar is scheduled to discuss the plan and recent company progress.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ASX Release 2 November 2026 ASX code: PIQ Proteomics International Laboratories Ltd launches Share Purchase Plan HIGHLIGHTS: • Proteomics invites eligible shareholders to participate in a Share Purchase Plan (SPP) to raise up to A$5,000,000 (before costs.) • SPP launch follows recent commercial...
Proteomics International Laboratories Ltd. on 6ix
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories